Suzanne M. de la Monte

23.2k total citations · 4 hit papers
288 papers, 18.5k citations indexed

About

Suzanne M. de la Monte is a scholar working on Molecular Biology, Physiology and Epidemiology. According to data from OpenAlex, Suzanne M. de la Monte has authored 288 papers receiving a total of 18.5k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Molecular Biology, 87 papers in Physiology and 44 papers in Epidemiology. Recurrent topics in Suzanne M. de la Monte's work include Alzheimer's disease research and treatments (56 papers), Prenatal Substance Exposure Effects (30 papers) and Liver Disease Diagnosis and Treatment (30 papers). Suzanne M. de la Monte is often cited by papers focused on Alzheimer's disease research and treatments (56 papers), Prenatal Substance Exposure Effects (30 papers) and Liver Disease Diagnosis and Treatment (30 papers). Suzanne M. de la Monte collaborates with scholars based in United States, Brazil and Australia. Suzanne M. de la Monte's co-authors include Jack R. Wands, Ming Tong, Lisa Longato, Rose Tavares, Grover M. Hutchins, Gary Moore, Benjamin M. Terry, Eric van Steen, Xiangdong Xu and Jillian J. Kril and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Suzanne M. de la Monte

284 papers receiving 18.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes?

2005 1.4k citations Jack R. Wands, Suzanne M. de la Monte et al. Journal of Alzheimer s Disease profile →
Alzheimer's Disease is Type 3 Diabetes—Evidence Reviewed

2008 830 citations Suzanne M. de la Monte, Jack R. Wands profile →
Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: Link to brain reductions in acetylcholine

2005 594 citations Jack R. Wands, Suzanne M. de la Monte et al. Journal of Alzheimer s Disease profile →
Brain metabolic dysfunction at the core of Alzheimer's disease

2014 337 citations Suzanne M. de la Monte, Ming Tong profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Suzanne M. de la Monte United States	70	7.0k	6.3k	2.5k	2.4k	2.4k	288	18.5k
Frank M. Faraci United States	75	7.2k 1.0×	5.1k 0.8×	2.3k 0.9×	1.4k 0.6×	1.1k 0.4×	307	19.0k
Zoltán Ungvári United States	86	7.6k 1.1×	7.0k 1.1×	1.1k 0.4×	2.6k 1.1×	1.7k 0.7×	412	24.6k
James K. Liao United States	96	6.4k 0.9×	11.5k 1.8×	1.4k 0.5×	2.9k 1.2×	4.5k 1.9×	280	35.1k
Ulrich Förstermann Germany	87	16.4k 2.3×	8.8k 1.4×	3.0k 1.2×	1.3k 0.5×	2.4k 1.0×	263	32.4k
Jeffrey N. Keller United States	77	6.6k 0.9×	7.6k 1.2×	2.5k 1.0×	1.9k 0.8×	686 0.3×	226	17.3k
Edwin K. Jackson United States	71	2.4k 0.3×	5.8k 0.9×	1.6k 0.6×	1.4k 0.6×	2.4k 1.0×	502	19.4k
Mohan K. Raizada United States	75	4.4k 0.6×	9.9k 1.6×	2.8k 1.1×	777 0.3×	4.2k 1.7×	434	22.2k
Christopher G. Sobey Australia	64	3.7k 0.5×	4.7k 0.8×	964 0.4×	1.7k 0.7×	1.3k 0.5×	232	15.3k
György Haskó United States	82	2.2k 0.3×	5.6k 0.9×	1.8k 0.7×	2.1k 0.8×	1.5k 0.6×	231	21.3k
Paul M. Vanhoutte Hong Kong	89	15.8k 2.2×	7.5k 1.2×	1.9k 0.8×	1.5k 0.6×	4.2k 1.8×	432	29.7k

Countries citing papers authored by Suzanne M. de la Monte

Since Specialization

Citations

This map shows the geographic impact of Suzanne M. de la Monte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne M. de la Monte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne M. de la Monte more than expected).

Fields of papers citing papers by Suzanne M. de la Monte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne M. de la Monte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne M. de la Monte. The network helps show where Suzanne M. de la Monte may publish in the future.

Co-authorship network of co-authors of Suzanne M. de la Monte

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne M. de la Monte. A scholar is included among the top collaborators of Suzanne M. de la Monte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne M. de la Monte. Suzanne M. de la Monte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Monte, Suzanne M. de la, et al.. (2025). Progressive Alcohol-Related Brain Atrophy and White Matter Pathology Are Linked to Long-Term Inhibitory Effects on mTOR Signaling. Biomolecules. 15(3). 413–413. 3 indexed citations

Monte, Suzanne M. de la, et al.. (2025). Dietary Soy Preserves Cognitive Function in Experimental Fetal Alcohol Spectrum Disorder: Role of Increased Signaling through Notch and Gonadotropin Releasing Hormone Networks. Journal of Behavioral and Brain Science. 15(2). 11–46. 1 indexed citations

Monte, Suzanne M. de la. (2023). Malignant Brain Aging: The Formidable Link Between Dysregulated Signaling Through Mechanistic Target of Rapamycin Pathways and Alzheimer’s Disease (Type 3 Diabetes). Journal of Alzheimer s Disease. 95(4). 1301–1337. 16 indexed citations

Punsoni, Michael, et al.. (2023). Post-Polio Syndrome Revisited. Neurology International. 15(2). 569–579. 9 indexed citations

Gameiro‐Ros, Isabel, Lelia Noble, Ming Tong, Emine Yalçın, & Suzanne M. de la Monte. (2023). Tissue Microarray Lipidomic Imaging Mass Spectrometry Method: Application to the Study of Alcohol-Related White Matter Neurodegeneration. SHILAP Revista de lepidopterología. 2(2). 173–193. 3 indexed citations

Monte, Suzanne M. de la, et al.. (2018). Therapeutic Advantages of Dual Targeting of PPAR-δ and PPAR-γ in an Experimental Model of Sporadic Alzheimer’s Disease. PubMed. 5(1). 1–8. 19 indexed citations

Mandelbaum, David E., et al.. (2018). Neuroinflammation-Related Encephalopathy in an Infant Born Preterm Following Exposure to Maternal Diabetic Ketoacidosis. The Journal of Pediatrics. 197. 286–291.e2. 1 indexed citations

Mandelbaum, David E. & Suzanne M. de la Monte. (2016). Adverse Structural and Functional Effects of Marijuana on the Brain: Evidence Reviewed. Pediatric Neurology. 66. 12–20. 40 indexed citations

Monte, Suzanne M. de la, et al.. (2016). Placental Morphology in Fetal Alcohol Spectrum Disorders. Alcohol and Alcoholism. 52(2). 138–144. 35 indexed citations

10.

Tong, Ming, et al.. (2016). Tobacco Smoke-Induced Brain White Matter Myelin Dysfunction: Potential Co-Factor Role of Smoking in Neurodegeneration. Journal of Alzheimer s Disease. 50(1). 133–148. 38 indexed citations

11.

Gao, Jinsong, et al.. (2015). Potential Role of Phosphorylation as a Regulator of Aspartyl-(asparaginyl)-β-hydroxylase: Relevance to Infiltrative Spread of Human Hepatocellular Carcinoma. Liver Cancer. 4(3). 139–153. 9 indexed citations

12.

Cattaneo, Chiara, Suzanne M. de la Monte, Alessandra Algarotti, et al.. (2011). A randomized comparison of caspofungin versus antifungal prophylaxis according to investigator policy in acute leukaemia patients undergoing induction chemotherapy (PROFIL-C study). Journal of Antimicrobial Chemotherapy. 66(9). 2140–2145. 24 indexed citations

13.

Silbermann, Elizabeth, et al.. (2010). Role of aspartyl-(asparaginyl)-β-hydroxylase mediated notch signaling in cerebellar development and function. Behavioral and Brain Functions. 6(1). 68–68. 26 indexed citations

14.

Monte, Suzanne M. de la, Maoyin Pang, Ming Tong, et al.. (2006). Aspartyl-asparagyl β hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms. Hepatology. 44(2). 446–457. 136 indexed citations

15.

Maemura, Koji, Suzanne M. de la Monte, Michael T. Chin, et al.. (2000). CLIF, a Novel Cycle-like Factor, Regulates the Circadian Oscillation of Plasminogen Activator Inhibitor-1 Gene Expression. Journal of Biological Chemistry. 275(47). 36847–36851. 168 indexed citations

16.

Monte, Suzanne M. de la, YongYao Xu, Grover M. Hutchins, & Jack R. Wands. (1996). Developmental patterns of neuronal thread protein gene expression in Down syndrome. Journal of the Neurological Sciences. 135(2). 118–125. 16 indexed citations

17.

Monte, Suzanne M. de la, Rolf I. Carlson, Nancy V. Brown, & Jack R. Wands. (1996). Profiles of Neuronal Thread Protein Expression in Alzheimer's Disease. Journal of Neuropathology & Experimental Neurology. 55(10). 1038–1050. 1 indexed citations

18.

Lee, M E, Suzanne M. de la Monte, Siew C. Ng, Kenneth D. Bloch, & Thomas Quertermous. (1990). Expression of the potent vasoconstrictor endothelin in the human central nervous system.. Journal of Clinical Investigation. 86(1). 141–147. 200 indexed citations

19.

Monte, Suzanne M. de la, C Bour, V.V. Radhakrishnan, et al.. (1988). Effects of cyclosporin A and predegeneration on survival and regeneration of peripheral nerve allografts in rabbits. Surgical Neurology. 29(2). 95–100. 8 indexed citations

20.

Pomerantz, Roger J., Daniel R. Kuritzkes, Suzanne M. de la Monte, et al.. (1987). Infection of the Retina by Human Immunodeficiency Virus Type I. New England Journal of Medicine. 317(26). 1643–1647. 148 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact